Decision Makers
Board of Directors
| Organization |
Position |
Status |
| AnorMED, Inc. |
Vice President, R & D & Chief Scientific Officer |
Current |
| Johnson Matthey, Inc. |
|
Former |
| University of Manchester Institute of Science and Technology |
Ph.D. in Chemistry |
Former |
| Boston College |
did post-doctoral research |
Former |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Vice President, Chemistry |
Current |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Director of Information Technology |
Current |
| Naval Postgraduate School |
Master Degree In Computer Science |
Former |
| Organization |
Position |
Status |
| AnorMED, Inc. |
National Marketing Director |
Current |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Programmer Analyst |
Current |
Jerry Jurgensen is chief executive officer of Nationwide, one of the largest diversified insurance and financial services companies in the world. He was elected to this position in July 2000. With an emphasis on financial discipline and an improved corporate culture, Jurgensen has led Nationwide to high levels of performance. During his tenure, Nationwide's net income has increased from $138 million in 2001 to $2 billion in 2006 and 2007. Jurgensen previously served as executive vice president of Bank One Corporation, where he headed corporate banking and commercial banking products. Prior to that, he was executive vice president of Norwest Corporation. He is a member of numerous business and civic organizations, including the boards of the Law Enforcement Foundation of Ohio, Ohio State University Hospital and Nationwide Children's Hospital. He also is a member of the Financial Services Roundtable, The Ohio Business Roundtable, The Business Roundtable, Columbus Downtown Development Corporation and The Columbus Partnership. He is co-chair of the Ohio Governor's Public-Private Collaborative Commission. Additionally, Jurgensen serves on the board of Achieve, Inc., and is a member of the Business Higher Education Forum. He also serves on the board of directors for ConAgra Foods, Inc. Jurgensen earned a bachelor's degree in finance and an MBA from Creighton University.
| Organization |
Position |
Status |
| Nationwide Autowatch |
Chief Executive Officer |
Current |
| Nationwide Federal Credit Union |
Chief Executive Officer |
Current |
| AnorMED, Inc. |
|
Current |
| Columbus Downtown Development Corporation |
Board of Directors |
Current |
| The Financial Services Roundtable |
Board of Directors |
Current |
| Loyola University |
Board of Directors |
Current |
| Nationwide Mutual Insurance Company |
Chief Executive Officer |
Former |
| Achieve Inc. |
Board of Directors |
Current |
| Norwest Corporation |
Executive Vice President |
Former |
| Bank One Corp |
Executive Vice President |
Former |
| Creighton University |
MBA |
Former |
| Creighton University |
Bachelor's Degree In Finance |
Former |
Mr. Brennan joined Aspreva from AnorMED Inc. where he recently held the title of Acting President & VP Business Development. Mr. Brennan also participated as an active member in AnorMED's Board of Directors, representing the management team and providing operational updates. Previously in his role as Vice President of Business Development at AnorMed, he was responsible for product strategy, marketing, corporate and strategic planning, business development, and licensing. This position also involved extensive external contact with potential collaborators in the US, EU and Japan and included most of the top 20 pharmaceutical and biotech companies. Prior to his tenure at AnorMED, Mr. Brennan held the positions of Director, Global Licensing at AstraZeneca plc in Alderley Park in the UK and Director, Business Development and Licensing at Astra Draco AB, a subsidiary within Astra AB. Mr. Brennan holds a M.Sc. in Physiology as well as a B.Sc (Hons) in Life Sciences from Queen's University in Kingston, Ontario.He lectures at the Simon Frazer University MBA Biotechnology Program.
| Organization |
Position |
Status |
| AnorMED, Inc. |
Board of Directors |
Current |
| Kansas Wind Power |
Cfo |
Former |
| Wells Fargo Bank |
Vice President of Strategy and Finance |
Former |
| Andersen Corporation |
|
Former |
| University of California Santa Cruz |
BA In Economics |
Former |
Ms. Walker has a degree in Communication Design from Johnson County Community College and 14 years experience in that field. Her additional 15+ years of experience in multiple industries (including non-profit, government, insurance, engineering, accounting, wholesale and manufacturing) gives her an ideal understanding of the requirements of business. Ms. Walker is the Owner/Designer of Intuitive Design. She is a member of several environmental organizations and has a personal goal to advance sustainable design practices in existing and new construction for the average home owner.
| Organization |
Position |
Status |
| Intuitive Design Corporation |
Owner |
Current |
| AnorMED, Inc. |
Board of Directors |
Current |
M Christopher DeVolder is the Director of Sustainability and an Architect and Associate for CDFM2 Architecture. Mr. DeVolder has over 10 years experience in sustainable design on the commercial and residential markets. His desire to provide a better world for his children has fueled his passion for sustainable design and renewable energy. As a LEED (Leadership in Energy and Environmental Design) Accredited Professional, Mr. DeVolder has provided leadership in the sustainable design field to a diversity of clients and consultants. Mr. DeVolder serves as the Chairman of the American Institute of Architects Committee on the Environment for Kansas City. This group has put together a number of critically acclaimed seminars and programs in sustainable design the past two years. With his involvement in the Prairie Village Environmental Committee, the annual Earth Fair of Prairie Village has grown in attendance by 50% a year the last two years. He has lectured on sustainable design throughout the country and participated in the Buildings for a Livable Future workshop and the Green By Design conference. Mr. DeVolder is a member of the prestigious Centurions Leadership Program through the Kansas City Chamber of Commerce, a 2 year program to develop the region s top young leaders recognized for their civic and professional accomplishments. Mr. DeVolder is the founder of zero3, a Kansas City company specializing in sustainable design and renewable energy.
| Organization |
Position |
Status |
| The Architecture Company |
Director of Sustainability |
Current |
| The Architecture Company |
Architect |
Current |
| AnorMED, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| Haynes Capital Corp |
|
Current |
| Scandipharm, Inc. |
Chairman, Corporate Governance and Nominating Committee, Member, Compensation Committee |
Current |
| AnorMED, Inc. |
Director |
Current |
| Axcan Pharma, Inc. |
Board of Directors |
Current |
| Urso Fortetm |
Board of Directors |
Current |
| Corporate Governance |
Board of Directors |
Current |
| Ultrase |
Board of Directors |
Current |
| Methylgene Inc |
Director |
Current |
| Isotechnika Inc. |
Director |
Current |
| Migenix, Inc. |
Director |
Current |
| Novartis AG |
Officer |
Former |
| Canadian Association |
Chair |
Former |
| Urso Fortetm |
Chairman, Corporate Governance and Nominating Committee, Member, Compensation Committee |
Former |
| Cambridge University |
B.A. Degree |
Former |
| Corporate Governance |
Member |
Former |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| Theravance, Inc. |
Board of Directors |
Current |
| Vertex Pharmaceuticals Incorporated |
Board of Directors |
Current |
| Phase Forward Incorporated |
Board of Directors |
Current |
| AnorMED, Inc. |
Board of Directors |
Current |
| Merck & Co. Inc. |
chief safety officer |
Former |
| Merck & Co. Inc. |
Vice President, and later Senior Vice President of Clinical and Regulatory Development |
Former |
| Merck & Co. Inc. |
Executive Director of Biochemistry and Molecular Biology |
Former |
| Merck & Co. Inc. |
Senior Director |
Former |
| VaxGen, Inc. |
Board of Directors |
Former |
| Vassar College |
A.B. Degree |
Former |
Dr. Felix J. Baker has served as a director of Neurogen Corporation since May 1999. Dr. Baker is a Managing Member of Baker Bros. Advisors, LLC, which he and his brother, Julian Baker, founded in 2000. Dr. Baker's firm manages Baker Brothers Investments, a family of long-term investment funds for major university endowments and foundations, which are focused on publicly traded life sciences companies. Dr. Baker's career as a fund-manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker holds a B.S. and a Ph.D. in Immunology from Stanford University, where he also completed two years of medical school. He is also a director of Conjuchem Inc., Seattle Genetics, Inc., and Trimeris, Inc.
| Organization |
Position |
Status |
| Neurogen Corporation |
Managing Partner, Baker Brothers Investments |
Current |
| Conjuchem Inc |
Director, Managing Partner, Baker Brothers Investments |
Current |
| Seattle Genetics, Inc. |
Chairman |
Current |
| Synageva Biopharma Corp. |
Chairman of The Board |
Current |
| Seattle Genetics, Inc. |
Director |
Current |
| Presidio Pharmaceuticals, Inc. |
Board of Directors |
Current |
| Conjuchem Inc |
Board of Directors |
Current |
| AnorMED, Inc. |
Director |
Current |
| Trimeris, Inc. |
Board of Directors |
Current |
| Baker Bros |
Managing Member |
Current |
| Neurogen Corporation |
Director |
Current |
| Trimeris, Inc. |
Director |
Former |
| Stanford University |
Doctorate In Immunology |
Former |
| Stanford University |
Bachelor's Degree In Biology |
Former |
| Organization |
Position |
Status |
| QLT, Inc. |
Chief Scientific Officer |
Current |
| QLT, Inc. |
Vice President |
Current |
| AnorMED, Inc. |
Board of Directors |
Current |
| QLT, Inc. |
Board of Directors |
Current |
| QLT, Inc. |
Chief Executive Officer |
Former |
| QLT, Inc. |
President |
Former |
| QLT, Inc. |
co-founder |
Former |
| QLT, Inc. |
Executive Chairman |
Former |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| BC Business Magazine |
|
Current |
| Inex Pharmaceuticals Corporation |
Director |
Current |
| Protiva Biotherapeutics |
Board of Directors |
Current |
| Migenix, Inc. |
Director |
Current |
| AnorMED, Inc. |
Board of Directors |
Current |
| AnorMED, Inc. |
CEO |
Former |
| AnorMED, Inc. |
President |
Former |
| AnorMED, Inc. |
Co-Founder |
Former |
| University of British Columbia |
Adjunct Professor |
Former |
| Johnson Matthey, Inc. |
|
Former |
| Massachusetts Institute |
Ph.D. In Chemistry |
Former |
| Massachusetts Institute of Technology |
Ph.D. in chemistry |
Former |
| Bowdoin College |
BA In Chemistry |
Former |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| AnorMED, Inc. |
Board of Directors |
Current |
| Spectral Diagnostics Inc. |
Board of Directors |
Former |
| York University |
Master of Business Administration |
Former |
| University of Toronto |
Master of Science degree |
Former |
| The University of Western Ontario |
M.D |
Former |